In addition, TSH stimulation, along with combination treatment with BRAF inhibitor and histone deacetylase (HDAC) inhibitor, maximized the synergistic effects of restoring thyroid-specific gene expression and RAI uptake in BRAF-mutated thyroid cancer 19. Here, HDAC9 is linked to thyroid gland carcinoma.